Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 16.54
+0.10 (0.61%)
Jul 30, 2026, 4:08 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 7.37 billion as of July 30, 2026. Its market cap has decreased by -41.43% in one year.
Market Cap
7.37B
Enterprise Value
5.28B
Revenue
2.73B
Ranking
n/a
PE Ratio
14.29
Stock Price
16.54
ChartMarket Cap Chart
Since April 30, 2015, HKG:6826's market cap has decreased from 9.34B to 7.37B, a decrease of -21.14%. That is a compound annual growth rate of -2.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 7.37B | -27.53% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shaanxi Micot Pharmaceutical Technology | 9.34B |
| Everest Medicines | 8.79B |
| TenNor Therapeutics (Suzhou) | 8.57B |
| Lepu Biopharma | 8.16B |
| CARsgen Therapeutics Holdings | 8.03B |
| Suzhou Ribo Life Science | 7.89B |
| Alphamab Oncology | 7.32B |
| Abbisko Cayman | 7.11B |